The epidemiology of osteoporosis and fractures in geriatric medicine

Clinics in Geriatric Medicine

Volumn 19, Issue 2, 2003, Pages 245-258

  Wehren, Lois E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; BONE DENSITY; BONE MINERAL; CIGARETTE SMOKING; ETHNIC GROUP; FALLING; FAMILY HISTORY; FEMALE; FRACTURE; GERIATRIC PATIENT; HIP FRACTURE; HUMAN; MALE; OSTEOPOROSIS; OVARIECTOMY; POPULATION RISK; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE;

AGED; FRACTURES, BONE; GERIATRICS; HUMANS; OSTEOPOROSIS; RISK FACTORS;

EID: 0037407659     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(02)00072-1     Document Type: Review

References (126)

1. National Institutes of Health Consensus Development Panel. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-95.
2. Martin B. Aging and strength of bone as a structural material. Calcif Tissue Int 1993;53: S34-40.
3. Cummings SR, Black D. Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. Am J Med 1995;98:24S-8S.
4. Einhorn TA. Bone strength: the bottom line. Calcif Tissue Int 1992;51:333-9.
5. World Health Organization. Assessment of fracture risk and application to screening for postmenopausal osteoporosis. Geneva, Switzerland: World Health Organization; 1994. WHO Technical Report Series; 843.
6. National Osteoporosis Foundation. America's bone health: the state of osteoporosis and low bone mass in our nation. Washington, DC: National Osteoporosis Foundation; 2002.
7. National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporos Int 1998;8:S1-88.
8. Looker AC, Johnston CCJ, Wahner HW, et al. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res 1995;10:796-802.
9. Ettinger B, Sidney S, Cummings SR, et al. Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences. J Clin Endocrinol Metab 1997;82:429-34.
10. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8:468-89.
11. Luckey MM, Meier DE, Mandeli P, et al. Radial and vertebral bone density in white and black women: evidence for racial differences in premenopausal bone homeostasis. J Clin Endocrinol Metab 1989;69:762-70.
12. Alekel DL, Mortillaro E, Hussain EA, et al. Lifestyle and biologic contributors to proximal femur bone mineral density and hip axis length in two distinct ethnic groups of premenopausal women. Osteoporos Int 1999;9:327-38.
13. Bhudhikanok GS, Wang M-C, Eckert K, et al. Differences in bone mineral in young Asian and Caucasian Americans may reflect differences in bone size. J Bone Miner Res 1996;11:1545-56.
14. Cundy T, Cornish J, Evans MC, et al. Sources of interracial variation in bone mineral density. J Bone Miner Res 1995;10:368-73.
15. Davis JW, Novotny R, Ross PD, Wasnich RD. The peak bone mass of Hawaiian, Filipino, Japanese, and white women living in Hawaii. Calcif Tissue Int 1994;55:249-52.
16. Evers SE, Orchard JW, Haddad RG. Bone density in postmenopausal North American Indian and Caucasian females. Hum Biol 1985;57:719-26.
17. Perry HM, Bernard M, Horowitz M, et al. The effect of aging on bone mineral metabolism and bone mass in Native American women. J Am Geriatr Soc 1998;46:1418-22.
18. Faulkner K, Miller PD, Barrett-Connor E, et al. Age, ethnicity, and bone mineral density at the heel: evidence from the National Osteoporosis Risk Assessment (NORA) program [abstract]. Bone 1998;23:S474.
19. Christiansen C, Christensen MS, Transbol I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981;1:459-61.
20. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980;2:1151-4.
21. Rae MH, Mole PA, Paterson CR. Endogenous factors affecting bone mineral content in postmenopausal women. Maturitas 1991;13:319-24.
22. Slemenda C, Hui SL, Longcope C, Johnston CC. Sex steroids and bone mass: a study of changes about the time of menopause. J Clin Invest 1987;80:1261-9.
23. Christiansen C, Christiansen MS, McNair P, et al. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980;10:273-9.
24. Lindsay R, Aitken JM, Anderson JB, et al. Long-term prevention of postmenopausal osteoporosis by oestrogen: evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976;1:1038-40.
25. Lindsay R, MacLean A, Kraszewski A, et al. Bone response to termination of oestrogen treatment. Lancet 1978;1:1325-7.
26. Khosla S, Melton LJ, Atkinson EJ, et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998;83:2266-74.
27. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998;339:599-603.
28. Carani C, Qin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997;337:91-5.
29. Khosla S, Melton LJI, Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001;86:3555-61.
30. Slemenda CW, Longcope C, Zhou L, et al. Sex steroids and bone mass in older men: positive associations with serum estrogens and negative associations with androgens. J Clin Invest 1997; 100:1755-9.
31. Falahati-Nini A, Riggs BL, Atkinson EJ, et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000;106:1553-60.
32. Soroko SB, Barrett-Connor E, Edelstein SL, Kritz-Silverstein D. Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bemardo study. J Bone Miner Res 1994;9:761-9.
33. Arden NK, Baker J, Hogg C, et al. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 1996;11: 530-4.
34. Christian JC, Yu P-L, Slemenda CW, Johnston CCJ. Heritability of bone mass: a longitudinal study in aging male twins. Am J Hum Genet 1989;44:429-33.
35. Flicker L, Hopper JL, Rodgers L, et al. Bone density determinants in elderly women: a twin study. J Bone Miner Res 1995;10:1607-13.
36. Jouanny P, Guillemin F, Kuntz C, et al. Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families. Arthritis Rheum 1995;38:61-7.
37. Pocock NA, Eisman JA, Hopper JL, et al. Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987;80:706-10.
38. Ralston SH. The genetics of osteoporosis. Bone 1999;25:85-6.
39. Smith DM, Nance WE, Kang KW, et al. Genetic factors in determining bone mass. J Clin Invest 1973;52:2800-8.
40. Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 1996;11:1841-9.
41. Grant SFA, Reid DM, Blake G, et al. Reduced bone density and osteoporosis associated with a polymorphic Sp 1 binding site in the collagen Type 1-alpha-1 gene. Nat Genet 1996;14:203-5.
42. Harris SS, Patel MS, Cole DEC, Dawson-Hughes B. Associations of the collagen type 1-alpha-1 Sp1 polymorphism with five-year rates of bone loss in older adults. Calcif Tissue Int 2000; 66:268-71.
43. Sainz J, van Tornout JM, Sayre J, et al. Association of collagen Type 1-alpha-1 gene polymorphism with bone density in early childhood. J Clin Endocrinol Metab 1999;84:853-5.
44. Kobayashi S, Inoue S, Ouchi Y, et al. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996;11:306-11.
45. Mizunuma H, Hosoi T, Okano H, et al. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone 1997;21:379-83.
46. Salmen T, Heikkinen A-M, Mahonen A, et al. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. J Bone Miner Res 2000;15:315-21.
47. Masi L, Becherini L, Colli E, et al. Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women. Biochem Biophys Res Comm 1998;248:190-5.
48. Dohi Y, Iki M, Ohgushi H, et al. A novel polymorphism in the promoter region for the human osteocalcin gene: the possibility of a correlation with bone mineral density in postmenopausal Japanese women. J Bone Miner Res 1998;13:1633-9.
49. Salamone LM, Cauley JA, Zmuda J, et al. Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss. J Bone Miner Res 2000;15:308-14.
50. Murray RE, McGuigan FE, Grant SFA, et al. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 1997;21:89-92.
51. Langdahl BL, Knudsen JY, Jensen HK, et al. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997;20:289-94.
52. Yamada Y, Miyauchi A, Goto J, et al. Association of a polymorphism of the transforming growth factor-betal gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998;13:1569-76.
53. Little RD, Carulli JP, Del Mastro RG, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002;70:11-9.
54. Barrett-Connor E, Wehren L, Furman WD, et al. The effects of smoking recency, duration, and dose on bone mineral density: the National Osteoporosis Risk Assessment (NORA) [abstract]. J Bone Miner Res 2000;15:S416.
55. Egger P, Duggleby S, Hobbs R, et al. Cigarette smoking and bone mineral density in the elderly. J Epidemiol Community Health 1996;50:47-50.
56. Grainge MJ, Coupland CAC, Cliffe SJ, et al. Cigarette smoking, alcohol and caffeine consumption, and bone mineral density in postmenopausal women. Osteoporos Int 1998;8:355-63.
57. Kiel DP, Zhang Y, Hannan MT, et al. The effect of smoking at different life stages on bone mineral density in elderly men and women. Osteoporos Int 1996;6:240-8.
58. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001;68:259-70.
59. Dawson-Hughes B, Dallal GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323:878-83.
60. Dawson-Hughes B. Calcium supplementation and bone loss: a review of controlled clinical trials. Am J Clin Nutr 1991;54:274S-80S.
61. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337:670-6.
62. Elders PJM, Netelenbos JC, Lips P, et al. Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 1991;73:533-40.
63. Heaney RP. The importance of calcium intake for lifelong skeletal health. Calcif Tissue Int 2002;70:70-3.
64. Specker BL. Evidence for an interaction between calcium intake and physical activity on changes in bone mineral density. J Bone Miner Res 1996;11:1539-44.
65. Valimaki MJ, Karkkaninen M, Lamberg-Allardt C, et al. Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. BMJ 1994; 309:230-5.
66. Guthrie JR, Ebeling PR, Dennerstein L, Wark JD. Risk factors for osteoporosis: prevalence, change, and association with bone density. Medscape Women's Health 2000:5. http://www. medscape.com/Medscape/WomensHealth/journal/2000/vO.../pnt-wh7378.guth.htm.
67. Hannan MT, Felson DT, Dawson-Hughes B, et al. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 2000;15: 710-20.
68. Kroger H, Tuppurainen M, Honkanen R, et al. Bone mineral density and risk factors for osteoporosis - a population-based study of 1600 perimenopausal women. Calcif Tissue Int 1994;55:1-7.
69. Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996;61:3441-7.
70. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.
71. McKenzie R, Reynolds JC, O'Fallon A, et al. Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. J Rheumatol 2000;27: 2222-6.
72. Cummings SR, Black DM, Rubin SM. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 1989;149: 2445-8.
73. van Staa T-P, Dennison EM, Leufkens HGM, Cooper C. Epidemiology of fractures in England and Wales. Bone 2001;29:517-22.
74. Seeley RG, Browner WS, Nevitt MC, et al. Which fractures are associated with low appendicular bone mass in elderly women? Ann Intern Med 1991;115:837-42.
75. Melton LJ. Epidemiology of fractures. In: Riggs BL, Melton LJ, editors. Osteoporosis: etiology, diagnosis, and management. New York: Raven Press; 1988. p. 133-54.
76. Cooper C. The crippling consequences of fractures and their impact on quality of life. Am J Med 1997;103:12S-9S.
77. Ensrud KE, Thompson DE, Cauley JA, et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. J Am Geriatr Soc 2000;48:241-9.
78. Greendale GA, Barrett-Connor E, Ingles S, Halle R. Late physical and functional effects of osteoporotic fracture in women: the Rancho Bemardo study. J Am Geriatr Soc 1995;43: 955-61.
79. Kaukonen J-P, Porras M, Karaharju E. Anatomical results after distal forearm fractures. Ann Chirurg Gynaecol 1988;77:21-6.
80. Kaukonen J-P, Karaharju EO, Porras M, et al. Functional recovery after fractures of the distal forearm. Ann Chirurg Gynaecol 1988;77:27-31.
81. Ettinger B, Black DM, Palermo L, et al. Kyphosis in older women and its relation to back pain, disability and osteopenia: the Study of Osteoporotic Fractures. Osteoporos Int 1994;4: 55-60.
82. Gold DT. The clinical impact of vertebral fractures: quality of life in women with osteoporosis. Bone 1996;18:185S-9S.
83. Leidig-Bruckner G, Minne HW, Schlaich C, et al. Clinical grading of spinal osteoporosis: quality of life components and spinal deformity in women with chronic low back pain and women with vertebral osteoporosis. J Bone Miner Res 1997;12:663-75.
84. Office of Technology Assessment. Hip fracture outcomes in people age 50 and over. Washington, DC: US Government Printing Office; 1994. Background Paper OTA-BP-H-120.
85. Magaziner J, Simonsick EM, Kashner TM, et al. Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study. J Gerontol 1990;45:M101-7.
86. Magaziner J, Hawkes W, Hebel JR, et al. Recovery from hip fracture in eight areas of function. J Gerontol 2000;55A:M498-507.
87. Ray NF, Chan JK, Thamer M, Melton LJ. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:24-35.
88. Melton LJI. Hip fractures: a worldwide problem today and tomorrow. Bone 1993;14:S1-8.
89. Riggs BL, Melton LJI. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995;17:505S-11S.
90. Martin RB, Burr DB, Sharkey NA. Skeletal tissue mechanics. New York: Springer-Verlag; 1998.
91. Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom 1999;2:343-50.
92. Klotzbuecher C, Ross P, Landsman P, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15:721-39.
93. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001;286:2815-22.
94. Ashford RU, Luchetti M, McCloskey EV, et al. Studies of bone density, quantitative ultrasound, and vertebral fractures in relation to collagen type I alpha 1 alleles in elderly women. Calcif Tissue Int 2001;68:348-51.
95. Flicker L, Faulkner KG, Hopper JL, et al. Determinants of hip axis length in women aged 10-89 years: a twin study. Bone 1996;18:41-5.
96. Qureshi AM, McGuigan FEA, Seymour DG, et al. Association between COLIA1 Sp1 alleles and femoral neck geometry. Calcif Tissue Int 2001;69:67-72.
97. Efstathiadou Z, Tsatsoulis A, Ioannidis JPA. Association of collagen 1-alpha-1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res 2001;16:1586-92.
98. Langdahl BL, Ralston SH, Grant SFA, Eriksen EF. An Spl binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women. J Bone Miner Res 1998; 13:1384-9.
99. Mann V, Hobson EE, Li B, et al. A COLIA1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 2001;107: 899-907.
100. Uitterlinden AG, Burger H, Huang QY, et al. Relation of alleles of the collagen type 1-alpha-1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 1998;338:1016-21.
101. Luckey MM, Wallenstein S, Lapinski R, Meier DE. A prospective study of bone loss in African-American and white women - a clinical research center study. J Clin Endocrinol Metab 1996;81:2948-56.
102. Zmuda JM, Cauley JA, Danielson ME, et al. Vitamin D receptor gene polymorphisms, bone turnover, and rates of bone loss in older African-American women. J Bone Miner Res 1997; 12:1446-52.
103. Cummings SR, Cauley JA, Palermo L, et al. Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Osteoporos Int 1994;4:226-9.
104. Wang M-C, Aguirre M, Bhudhikanok GS, et al. Bone mass and hip axis length in healthy Asian, black, Hispanic, and white American youths. J Bone Miner Res 1997;12:1922-35.
105. Wehren L, Magaziner J. Prevention of falls. In: Obrant K, editor. Management of fractures in severely osteoporotic bone. London: Springer; 2000. p. 333-52.
106. Campbell AJ, Reinken J, Allan BC, Martinez GS. Falls in old age: a study of frequency and related clinical factors. Age Ageing 1981;10:264-70.
107. Campbell AJ, Borrie MJ, Spears GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol 1989;44:M112-7.
108. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701-7.
109. Baker SP, Harvey AH. Fall injuries in the elderly. Clin Geriatr Med 1985;1:501-12.
110. Kellogg International Work Group. The prevention of falls in later life: a report of the Kellogg International Work Group on the Prevention of Falls by the Elderly. Danish Med Bull 1987; 34:1-24.
111. Lucht U. A prospective study of accidental falls and resulting injuries in the home among elderly people. Acta Sociomed Scand 1971;2:105-20.
112. Winner SJ, Morgan CA, Evans JG. Perimenopausal risk of falling and incidence of distal forearm fracture. BMJ 1989;298:1486-8.
113. Honkanen R, Tuppurainen M, Kroger H, et al. Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12,192 perimenopausal women. Osteoporos Int 1998;8:25-31.
114. Meyer HE, Henriksen C, Falch JA, et al. Risk factors for hip fracture in a high incidence area: a case-control study from Oslo, Norway. Osteoporos Int 1995;5:239-46.
115. O'Connell D, Robertson J, Henry D, Gillespie W. A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects. Climacteric 1998;1:112-23.
116. Tuppurainen M, Kroger H, Honkanen R, et al. Risks of perimenopausal fractures - a prospective population-based study. Acta Obstet Gynecol Scand 1995;74:624-8.
117. Mussolino ME, Looker AC, Madans JH, et al. Risk factors for hip fracture in white men: the NHANES I epidemiologic follow-up study. J Bone Miner Res 1998;13:918-24.
118. Nguyen T, Sambrook P, Kelly P, et al. Prediction of osteoporotic fractures by postural instability and bone density. BMJ 1993;307:1111-5.
119. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1996;144:255-63.
120. Nguyen TV, Center JR, Sambrook PN, Eisman JA. Risk factors for proximal humerus, forearm, and wrist fractures in elderly men and women: the Dubbo Osteoporosis Epidemiology Study. Am J Epidemiol 2001;153:587-95.
121. Poor G, Atkinson EJ, O'Fallon WM, Melton LJI. Predictors of hip fractures in elderly men. J Bone Miner Res 1995;10:1900-7.
122. Seeley DG, Kelsey J, Jergas M, Nevitt MC. Predictors of ankle and foot fractures in older women. J Bone Miner Res 1996;11:1347-55.
123. Cook DJ, Guyatt GH, Adachi JD, et al. Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Group. Osteoporos Int 1999;10:207-13.
124. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985;7:178-208.
125. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332:767-73.
126. Kelsey JL, Browner WS, Seeley DG, et al. Risk factors for fractures of the distal forearm and proximal humerus. Am J Epidemiol 1992;135:477-89.